摘要 |
The invention relates to 4-oxo-2,3,4,5-tetrahydro-benzo [b][1,4]diazepines of formula I wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3 </SUP>and R<SUP>4 </SUP>are as defined in the description and claims, which are gamma-secretase inhibitors and which may be useful in the treatment of Alzheimer's disease.
|